Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marianna Adamo

Showing results (1-10 of 480) with videos related to

Pageof 48
Sort By:
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 9, 2020
Reply: Explaining differing outcomes from the COAPT and MITRA-FR trials using disproportionate and proportionate secondary mitral regurgitationMarianna Adamo, Marco Metra
International Journal of Cardiology|July 13, 2025
Reply to letter: Right heart failure and mortality in patients undergoing transcatheter tricuspid valve interventionsMatteo Pagnesi, Marianna Adamo
European Journal of Heart Failure|August 15, 2021
Cardiac output in severe tricuspid regurgitation: when more is lessMarco Guazzi, Marianna Adamo
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 19, 2021
Treatment of secondary mitral regurgitation in patients with heart failure: when left ventricular ejection fraction may become not crucialMarco Metra, Marianna Adamo
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 2, 2026
Durability of transcatheter mitral valve replacement: another step forwardMarianna Adamo, Elisa Pezzola
European Journal of Heart Failure|October 16, 2021
Can mild to moderate secondary mitral regurgitation be a therapeutic target for symptomatic patients with heart failure with reduced ejection fraction?Marianna Adamo, Marco Metra
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 8, 2025
Expanding the boundaries of M-TEER: is it time to treat moderate secondary mitral regurgitation?Marianna Adamo, Mauro Riccardi
JACC. Heart Failure|July 6, 2026
Pharmacologic Therapies for HFrEF Reduce Secondary Mitral Regurgitation: Is It Enough?Marianna Adamo, Elisa Pezzola
JACC. Cardiovascular Interventions|October 6, 2022
A Step Forward in Risk Stratification and Patient Selection for Mitral TEER in SMRMichele Pighi, Marianna Adamo
Internal and Emergency Medicine|January 16, 2020
Percutaneous treatment of mitral regurgitation: looking for a final modelMarianna Adamo, Marco Metra
Pageof 48

Showing results (1-10 of 480) with videos related to

Sort By:
Pageof 48
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 9, 2020
Reply: Explaining differing outcomes from the COAPT and MITRA-FR trials using disproportionate and proportionate secondary mitral regurgitationMarianna Adamo, Marco Metra
International Journal of Cardiology|July 13, 2025
Reply to letter: Right heart failure and mortality in patients undergoing transcatheter tricuspid valve interventionsMatteo Pagnesi, Marianna Adamo
European Journal of Heart Failure|August 15, 2021
Cardiac output in severe tricuspid regurgitation: when more is lessMarco Guazzi, Marianna Adamo
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 19, 2021
Treatment of secondary mitral regurgitation in patients with heart failure: when left ventricular ejection fraction may become not crucialMarco Metra, Marianna Adamo
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 2, 2026
Durability of transcatheter mitral valve replacement: another step forwardMarianna Adamo, Elisa Pezzola
European Journal of Heart Failure|October 16, 2021
Can mild to moderate secondary mitral regurgitation be a therapeutic target for symptomatic patients with heart failure with reduced ejection fraction?Marianna Adamo, Marco Metra
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 8, 2025
Expanding the boundaries of M-TEER: is it time to treat moderate secondary mitral regurgitation?Marianna Adamo, Mauro Riccardi
JACC. Heart Failure|July 6, 2026
Pharmacologic Therapies for HFrEF Reduce Secondary Mitral Regurgitation: Is It Enough?Marianna Adamo, Elisa Pezzola
JACC. Cardiovascular Interventions|October 6, 2022
A Step Forward in Risk Stratification and Patient Selection for Mitral TEER in SMRMichele Pighi, Marianna Adamo
Internal and Emergency Medicine|January 16, 2020
Percutaneous treatment of mitral regurgitation: looking for a final modelMarianna Adamo, Marco Metra
Pageof 48